8%) were treated with a total thyroidectomy and 45 (44%) patients received radioactive iodine therapy. All neoplasms are classified in this chapter, whether. Do not code replacement therapy as treatment . Metastases are most observed in the. There were 690 patients who were included in the statistical analysis who had sufficient data available on clinical features and outcomes. Malignant neoplasm of thyroid gland 193- >. Non-invasive follicular thyroid neoplasm with papillarylike nuclear features (NIFTP) is a new name for a very low risk thyroid tumor previously known as an Encapsulated Non-invasive Follicular Variant Papillary Thyroid Carcinoma. Code Version: 2022 ICD-10-CM. This is the American ICD-10-CM version of C48. It is predominantly indicated for palliation of locally advanced. Showing 1-25: ICD-10-CM Diagnosis Code C73 [convert to ICD-9-CM] Malignant neoplasm of thyroid gland. 912 is applicable to female patients. ICD-0 : 8260/3 – papillary. 0) For liver cancers, there are eight codes in the ICD-10-CM, with 6 of the codes designating a specified histology. ICD coding. Use ICD-10CM to code the following: The patient has papillary. Postprocedural hypothyroidism. GENERAL ICD-10 C73: Papillary thyroid ca. 912 became effective on October 1, 2023. 500 results found. The incidence of TC has increased rapidly in recent 30 years with a female to male ratio of 3:1 (2, 3). Microcarcinomas are thyroid cancers < 1 cm in size. Nodules that are 7-10 mm occasionally will exhibit suspicious features that do prompt a needle biopsy (fine needle aspiration). The study cohort was drawn from US Surveillance, Epidemiology, and End Results (SEER)‒18 data between 2004 and 2013. C53. 0 - other international versions of ICD-10 C75. This is the American ICD-10-CM version of C22. ” Journal of the Royal Society of Medicine, Sage, 1 July 2002,. , et al. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. malignant carcinoid tumor of the thymus (. 9. Cryoablation uses a gas to freeze and kill cancer cells. 2016; 122 (2):198–206. The recommendation is to use the active cancer (C) dx. ICD 10 code for Carcinoma in situ of other specified digestive organs. The 2024 edition of ICD-10-CM D44. It is a differentiated thyroid cancer, meaning that the tumor looks similar to normal thyroid tissue under a microscope. Malignant neoplasm of thyroid gland (C73) C72. We hope you find it helpful, and thanks for stopping by!Optic papillitis, unspecified eye. This study aimed to developed a clinical-ultrasound (Clin-US) nomogram to predict LLNM in patients with PTC. Search SEER Inquiries. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Purpose: To explore the risk factors that may predict the lymph node metastasis potential of these lesions and new prevention strategies in papillary thyroid carcinoma patients. 0 became effective on October 1, 2023. All neoplasms are classified in this chapter, whether. ICD-10 Games Learn codes with classic games like Flashcards and Hangman. Thyroid cancer is a malignant tumor that arises from either the thyrocytes or the parafollicular cells of the thyroid gland. Papillary muscle rupture; Rupture of papillary muscle; rupture of papillary muscle as current complication following acute myocardial infarction (I23. C79. 2 may differ. C15. Verified. This is the American ICD-10-CM version of D44. Cancer of the thyroid, metastatic to bone; Cancer of the thyroid, papillary; Cancer of the thyroid, with metastasis to bilateral lungs; Cancer of the thyroid, with metastasis to left lung; Cancer of the thyroid, with. C00-C14 Malignant neoplasms of lip, oral cavity and pharynx. There is another digit after the slash. C76. Page 6 of 15 MCR sC73P_E-ICD-10-C73-Papillary-thyroid-ca. 8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. a total thyroidectomy removes both lobes — the entire thyroid gland. 7 years in the present series. Get free rules, notes, crosswalks, synonyms, history for ICD-10 code Z85. 3 4 These low risk cancers are associated with an excellent long term survival; disease. Most patients are 25 to 65 years of age when first diagnosed; women are more affected than men. D44. Fontenot et al (2015) stated that re-operation for recurrent papillary thyroid cancer (PTC) can be associated with a high rate of complications and failure to. A total of 40,672 tumor records with a thyroid cancer diagnosis were identified using the primary site code C73. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 4; Surveillance Research Program of the National Cancer Institute). 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Thus, ICD-10 provides codes for leukemia and multiple myeloma to indicate if they have not achieved remission, are in remission, or in relapse. Total thyroidectomy is the treatment of choice for clinically significant papillary thyroid cancer (PTC); however, 10-15% develop palpable local recurrence in the cervical lymph nodes. H46. Malignant neoplasm of thyroid gland. ICD-10-CM Coding Rules. Benign neoplasm of thyroid gland. ” 3 The increasing incidence is solely attributable to papillary thyroid carcinoma (PTC), a tumor named for its papillary growth. 238 [convert to ICD-9-CM]The 2024 edition of ICD-10-CM O9A. Cancer. The 2024 edition of ICD-10-CM E07. The study group consisted of 435 females (76. In Western countries, frequency of follicular variant among all papillary carcinoma increased over the past few decades from 3. follicular M8330 3. Thyroid carcinoma (TC) is the most frequent endocrine malignancy, accounting for approximately 3. This free tool is designed to help billers and coders navigate the new ICD-10-CM code set. All neoplasms are classified in this chapter, whether. Based on their review they reclassified the tumors into: 32 cases (63%) of NIFTPs, 4 cases (7%) of an invasive encapsulated form of follicular variant papillary thyroid cancer, 14 cases. Thyroid Gland C739 . The code is exempt from present on admission (POA) reporting for. 3. The median survival time after. C22. ICD-9-CM 193 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 193 should only be used for claims with a date of service on or before September 30, 2015. Most papillary thyroid cancers are small and respond well to treatment, even if the cancer cells spread to the lymph nodes in the neck. Code Classification: Neoplasms (C00–D49) Malignant neoplasms of thyroid and other endocrine glands (C73-C75) Malignant neoplasm of thyroid gland (C73) C73 Malignant neoplasm of thyroid gland. variant of papillary thyroid carcinoma on rates of malignancy for fine-needle. 280 is grouped within Diagnostic Related Group(s) (MS-DRG v 41. Papillary thyroid carcinoma (PTC) is the most common form of well-differentiated thyroid cancer, and the most common form of thyroid cancer to result from exposure to radiation. This is the American ICD-10-CM version of O9A. 6 mm and showing an indistinct border can be seen in the right lobe of. general populations by year of diagnosis, sex, and other select. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 15. 850 ICD-10 code Z85. 5) ICD-10-CM Diagnosis Code S11. The 2024 edition of ICD-10-CM C76. Do not code replacement therapy as treatment unless the tumor is papillary and/or follicular. Code papillary carcinoma, tall cell variant with oncocytic features to papillary carcinoma, tall cell (C73. ICD coding. The study group consisted of 435 females (76. Thyroid Gland C739 . (>10 cm) as well as spreading to mediastinum. Most patients with well-differentiated thyroid cancer have resectable tumors, and the results from surgery, radioiodine, and thyroxine therapy are excellent. Usual ductal hyperplasia involving a papilloma is associated with a 7 fold increase in risk for. Code Hormone Therapy as 01 for follicular and/or papillary thyroid cancer when thyroid hormone therapy is given. Papillary thyroid cancer is the most common of all thyroid cancers (>85%). Short description: HX OF THYROID MALIGNANCY. The 2024 edition of ICD-10-CM C53. Papillary carcinoma appears as an irregular solid or cystic mass or nodule in a normal thyroid parenchyma. 10 Conventional, or classical, papillary thyroid carcinoma. ThyCa: Thyroid Cancer Survivors' Association, Inc. 2022. 9) with histologic codes 8050, 8260, 8340 to 8344, 8350, and. A, B: Computed tomography findings in the lung. 0 may differ. Because NIFTP tumors are. ATC is an uncommon form of thyroid cancer only accounting for 1-2% of cases, but due to its high mortality, is responsible for 20-50% of deaths from thyroid cancer. This is the American ICD-10-CM version of D44. Brain metastasis is a rare but serious complication of papillary thyroid cancer (PTC), affecting survival and quality of life. It is a differentiated thyroid cancer, meaning that the tumor looks similar to normal thyroid tissue under a microscope. 6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 0) For liver cancers, there are eight codes in the ICD-10-CM, with 6 of the codes designating a specified histology. Differentiated Thyroid cancer. Patients now present with central compartment metastatic disease after initial thyroid cancer surgery,. 9) Y Cases diagnosed 1/1/2017 forward New Term 8343/2 Non‐invasive encapsulated follicular variant of papillary thyroid carcinoma (non‐invasive EFVPTC) (C73. 1 may differ. 10XA [convert to ICD-9-CM] Unspecified open wound of thyroid gland, initial encounter. Coding Guidelines . This is the American ICD-10-CM version of C50. Cancer in situ of spleen; Cancer in situ pancreas, body. The 2024 edition of ICD-10-CM D09. 9 - benign neoplasm of unspecified ovary ICD-10: C56 - malignant neoplasm of ovary Epidemiology. 9 may differ. Open bite of thyroid gland. The aim of this review is to summarize the current literature and discuss prognostic and management implications of lymph node metastases in differentiated thyroid cancer. and papillary M8340 3 193. From 1975 to 2009, microscopic papillary thyroid carcinoma (mPTC) incidence skyrocketed 49%; yet, mortality remained stable. Most nodules are benign with only 5-10% of nodules being cancerous. C15. If this is the case, there are usually additional letters and numbers in addition to the code. Introduction. Lymphoma patients who are in remission are stillThyroid lymphoma is a rare cancer constituting 1% to 2% of all thyroid cancers and less than 2% of lymphomas. 5) ICD-10-CM Diagnosis Code S11. ICD-10-CM C73 is a billable/specific code for a primary or metastatic malignant neoplasm of the thyroid gland, including papillary thyroid carcinoma. 9) with. C15. It starts with the letter M, followed by 4 digits and then a slash. For 1,669 of 1,694 cases diagnosed between 1998 and 2006 valid data could be obtained for this item. The papillary type of thyroid cancer was verified using biopsy reports or the patients’ medical records. Stage II (T2, N0, M0): The tumor is more than 2 cm but not larger than 4 cm across and has not grown outside the thyroid. 1 - other international versions of ICD-10 C56. Column 1:30844924. Diagnostics 2020;10:1–9. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: an updated study with more than 2000 consecutive patients. Microcarcinomas are thyroid cancers < 1 cm in size. nodes of neck from thyroid; Secondary malignant neoplasm of right lung from thyroid; Thyroid cancer metastatic to bone; Thyroid cancer metastatic to unspecified site; code to identify any functional. Instruction stated codes as: 1) D70. Do not code replacement therapy as treatment unless the tumor is papillary and/or follicular. Get free rules, notes, crosswalks, synonyms, history for ICD-10 code O99. Papillary thyroid microcarcinoma is usually negative for p63, in contrast to the mimicker solid cell nests which are usually positive for. The 2024 edition of ICD-10-CM C54. There were 690 patients who were included in the statistical analysis who had sufficient data available on clinical features and outcomes. The 5- and 10-year overall survival in the patient group with papillary cancer was 97% and 95% respectively, in the group with follicular cancer it was 78% and 50% respectively and in the group with medullary cancer it was 91% and 82% respectively. When the biopsy diagnosis is in question, some patients. The ratio of follicular adenoma to follicular carcinoma in surgical specimen is approximately 5 to 1 [ 3 ]. 0 became effective on October 1, 2023. 6 - other international versions of ICD-10 C67. 8 to 14. unless the tumor is papillary. The majority of head and neck malignancies (90-95%) are squamous cell cancers (M-807_3). These microcarcinomas typically are papillary thyroid cancer, the most common type of thyroid cancer. 5 and 0. The prognosis for thyroid cancer in most patients is excellent, with an overall disease-specific survival (DSS) rate >90% for at least 10 years . 6 × 4. More than half of the patients required. There were 1039 eligible patients identified, including 51% (534) with multifocal papillary thyroid cancer. 8 became effective on October 1, 2023. Thyroid biopsy is the procedure of choice to identify patients who require surgery for a potential cancer, but it is not a perfect test. This type of cancer is more common in adults with a 2. C15. See also, ICD-10 Table of Neoplasms. C79. Recently, watchful waiting with serial cervical US evaluations would be considered a reasonable approach. (Papillary and Follicular) Thyroid cancer is relatively uncommon compared to other cancers. It’s characterized by finger-like extensions of cancer. hematopoietic and reticuloendothelial systems (C42) 6. Specialty: Oncology. Overall, patients with thyroid cancer have an excellent prognosis, with a 5-year survival rate of 95% or higher and a recurrence rate of 20% or lower. Papillary thyroid cancer is one of the most common types of thyroid cancer. Look in the ICD-10-CM Alphabetic Index for Cancer - see also Neoplasm, by site, malignant. , 2–6%) and distant recurrence rates (i. Crossref , Medline , Google ScholarBackground: Poorly differentiated thyroid cancer (PDTC) is a rare but clinically highly significant entity because it accounts for most fatalities from non-anaplastic follicular cell-derived thyroid cancer. Enlargement of the thyroid gland. Papillary subtype was by far the most prevalent in all races, accounting for 85% of total cases. 43% of all thyroid cancers and 50% of new cases of papillary thyroid carcinoma are papillary microcarcinoma. This study examined the risk of survival in patients with small thyroid cancers that were treated total thyroidectomy vs lobectomy. Adjuvant EBRT was not associated with survival benefit in the initial management of locally invasive papillary thyroid cancer. PTC is a slowly progressive cancer with high survival rate. We identified the three major PTC variants using the ICD-O-3 code (International Classification of Diseases for Oncology third edition) as follows: Papillary carcinoma of thyroid = 8260; Papillary carcinoma, Follicular variant = 8340/3; Papillary carcinoma, tall cell = 8344. doi: 10. We aimed to identify the risk factors for multifocality and bilaterality, and investigate the significance of multifocality on prognosis in all PTC, papillary thyroid microcarcinoma. This is the American ICD-10-CM version of C50. Background: This study compares the pathological outcomes and operative morbidity for papillary thyroid cancer (PTC) patients undergoing a primary total thyroidectomy (TT) with central lymph node dissection (CLND), to those undergoing an interval CLND following a previous thyroid operation, or for the unsuspected diagnosis of PTC. The term "non-invasive follicular thyroid neoplasm with papillary-like nuclear features" is now being used, instead of the previous classification of an encapsulated malignant thyroid tumor. Free, official information about 2009 (and also 2010-2015) ICD-9-CM diagnosis code 193, including coding notes, detailed descriptions, index cross-references and ICD-10-CM conversion. This is the American ICD-10-CM version of C56. 2018 Dec 27;11(1):26. The 2024 edition of ICD-10-CM D44. 7%, compared with benign thyroid nodules, which demonstrated a pooled overall complication rate of 2. surg. 7 is grouped within Diagnostic Related Group(s) (MS-DRG v 41. The 2024 edition of ICD-10-CM H46. 1 became effective on October 1, 2023. Differentiated thyroid cancers generally have a very good prognosis, with a 10-year survival rate greater than 90% 1. 0 – N80. What are the ICD-10 codes for cancer? Malignant (primary) neoplasm, unspecified C80. 0 became effective on October 1, 2023. 113 - other international versions of ICD-10 O9A. In two autopsy series, the incidence of thyroid adenoma was 3 and 4. The ICD-10 code for papillary thyroid cancer is C73. The 2024 edition of ICD-10-CM C79. Liver (C22. C54. The mean follow-up period was 9. and morphology codes available in CCR. OCR Morphologic Codes ICD-O-3 80762 = Squamous cell carcinoma in situ with questionable Nonmelanoma Skin 80500 = Papilloma, NOS 80502 = Papillary carcinoma in situ 80503 = Papillary carcinoma, NOS 80510 = Verrucous papilloma 80513 = Verrucous carcinoma, NOS 80520 = Squamous cell papilloma, NOS 80522 = Papillary squamous. 10. 858. Papillary thyroid microcarcinoma (microPTC) is defined as a PTC with a maximum diameter of 10 mm, and it generally has an excellent prognosis. Thyroiditis (inflammation of thyroid) in pregnancy; Thyroiditis in pregnancy; ICD-10-CM O99. attention. Thus, ICD-10 provides codes for leukemia and multiple myeloma to indicate if they have not achieved remission, are in remission, or in relapse. Neoplasms. Look up free coding details for ICD-10 code range C73-C75 that cover Malignant neoplasms of thyroid and other endocrine glands. 0 became effective on October 1, 2023. ICD-10-CM Code. The code C73 is VALID for claim submission. Learn more about the importance of site-specific metastasis and survival in PTC by. Differentiated thyroid cancerThe PDF and Excel files for the ICD-O-3 SEER Site/Histology Validation List dated 4/25/2023 have since been removed from this site. 2. Type 1 Excludes. 1 is applicable to female patients. When the biopsy diagnosis is in question, some patients. 7 years. Z85. 00 - other international versions of ICD-10 H46. ICD-10-CM code: The patient has papillary thyroid cancer. Open bite of thyroid gland. 6 - other international versions of ICD-10 C67. Malignant neoplasms of thyroid and other endocrine glands. 9). 850 Personal history of malignant neoplasm of thyroid . (Sequence correctly. 87 should only be used for claims with a date of service on or before September 30, 2015. There are 5 main types of thyroid cancer: Not Papillary thyroid cancer. ICD 9 Codes: History of cancer of the stomach; History of malignant neoplasm of stomach; Conditions classifiable to C16. E89. Verify code selection in the Tabular List. Type 1 Excludes. The patient has papillary thyroid cancer that has spread to the lymph nodes of the cervical area of the neck. C00-C75 - Malignant neoplasms, stated or presumed to be primary (of specified sites), and certain specified histologies, except neuroendocrine, and of lymphoid, hematopoietic and related tissue. Expansile papillary tumor occurring in postmenopausal women with low or intermediate grade nuclei surrounded by a fibrous capsule that lacks myoepithelial cells along the papillae and at the periphery. A hypoechoic mass measuring 8. It has not spread to nearby lymph nodes (N0) or distant sites (M0). 850 became effective on October 1, 2023. appropriate for other thyroid cancers. The 2024 edition of ICD-10-CM C67. Papillary thyroid cancer (papillary thyroid carcinoma, PTC) is the most common type of thyroid cancer, representing 75 percent to 85 percent of all thyroid cancer cases. Malignant neoplasms. Total thyroidectomy 2. Papillary . 113 is applicable to maternity patients aged 12 - 55 years inclusive. The 2024 edition of ICD-10-CM C50. 8% of all newly diagnosed cancer (). THE FULL ARTICLE TITLE: Adam MA et al. Authors. Of the 667 patients with papillary thyroid cancer treated with radioactive iodine therapy, 570 patients were included in this study. 850 is considered exempt from POA reporting. Papillary carcinoma appears as an irregular solid or cystic mass or nodule in a normal thyroid parenchyma. Nodules that are 7-10 mm occasionally will exhibit suspicious features that do prompt a needle biopsy (fine needle aspiration). 89 (secondary malignant neoplasm of other specified sites). 99 per 100,000 (). It accounts for about 55–65% of cases. or in cases with high number of cancer foci. 00 may differ. No strong sex predilection (as compared with other thyroid diseases) (BMC Cancer 2015;15:330, Adv Anat Pathol 2006;13:69). , 86%–89% 5-year survival for MTC compared with 94%–98% 5-year survival for papillary and follicular thyroid cancer). Ultrasound features were used to determine salivary gland damage after radioactive iodine therapy. Papillary thyroid cancer. Papillary thyroid cancer (papillary thyroid carcinoma, PTC) is the most common type of thyroid cancer, representing 75 percent to 85 percent of all thyroid cancer cases. BACKGROUND. Design, setting,. 3%) with an average age of 43 years. ICD 10 code for Personal history of malignant neoplasm of other endocrine glands. ICD-10 code C73 for Malignant neoplasm of thyroid gland is a medical classification as listed by WHO under the range - Malignant neoplasms . Cibas, MD,1 and Syed Z. Code Hormone. ICD-10: C73 - malignant neoplasm of thyroid gland ICD-O:. (malignant) neoplasms of the thyroid gland (International Classification of Diseases for Oncology, third edition [ICD-O-3] topography code C73. Do not code replacement therapy as treatment . 17% lymph node metastasis were analyzed (Revman 5. This is the American ICD-10-CM version of C67. If the primary is thyroid and the pathology states papillary microcarcinoma or micropapillary carcinoma, code 8260 is correct. Methods. 193 Malignant neoplasm of thyroid gland convert 193 to ICD-10-CM. Most (77. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes). Predominant form of thyroid carcinoma, accounting for 80 - 93% in contemporary series (IARC: CI5 Cancer Incidence in Five Continents [Accessed 30 September 2019]) There is a growing number of papillary thyroid carcinoma in the last 15 - 20 years due to increasing recognition of thyroid nodules on imaging (ultrasound and CT), sometimes referred as thyroid cancer epidemics; most of these tumors. Search Results. Medullary thyroid cancer is a form of thyroid carcinoma which originates from the parafollicular cells (C cells), which produce the hormone calcitonin. 32. See full list on icdlist. 3390/cancers11010026. Hürthle cell cancer accounts for only about 3-10% of all differentiated thyroid cancers; therefore, few institutions have extensive experience with Hürthle cell neoplasms. KEYWORDS : lymph nodes, neck, neck dissection, outcomes, prognosis,. The median survival time after. 0000000000000520. 2 became effective on October 1, 2023. (Diagnosis to report if no further positive findings. 6 mm and showing an indistinct border can be seen in the right lobe of. The Bethesda System for Reporting Thyroid Cytopathology Edmund S. Patients with claims for International Classification of Diseases, 9th Revision (ICD-9) diagnosis codes 193 (Malignant neoplasm of thyroid gland) or V10. C67. Surgery . [5] [6] [7] A recent report of autopsy results showed no. 1 topography code C73. Subsequently, the patient was closely examined for a primary lesion in the thyroid gland. Search All ICD-10; ICD-10-CM Diagnosis Codes; ICD-10-PCS Procedure Codes; ICD-10-CM Diagnosis Index;. Use this two-page table to select combination histology codes. We followed the ICD-10-AM alphabetical index and came to: Carcinoma - papillary - - thyroid (M8260/3) But when we confirmed the definition in the ICD-10-AM tabular index we found that M8260/3 reads Papillary adenocarcinoma NOS. 5 mm were noted in the right lobe independent of the thyroid nodules detected on the preoperative ultrasound. The 2024 edition of ICD-10-CM C54. A corresponding procedure code must accompany a Z code if a procedure is performed. C74 - Malignant neoplasm of adrenal gland. US thyroid cancer incidence rates have increased substantially since the early 1980s, driven largely by an increase in papillary thyroid cancer (PTC), the most common histologic type (). Y & XH0134 - other specified carcinoma in situ of breast & solid papillary carcinoma in situ. External beam radiotherapy (EBRT) is used infrequently in the management of differentiated thyroid cancer. 2 inch. Since thyroid cancer is relatively common, and papillary thyroid cancer is the most common form of thyroid cancer, it is very likely that you will know somebody that. The 2024 edition of ICD-10-CM Z80. pt had thyroid cancer, fever and chemo drug induced agranulocytosis. This is the American ICD-10-CM version of D34 - other international versions of ICD-10 D34 may differ. 6 × 4. This is the American ICD-10-CM version of E89. by TNM staging. 0 may differ. About 80% to 85% of papillary thyroid cancers can be removed surgically. 87 (Personal history of malignant neoplasm of thyroid) during baseline were excluded to allow for identification of incident cancers during follow-up. The average rate of recurrence was 13. In subgroup analysis, RFA for recurrent malignant nodules demonstrated a pooled overall complication rate of 11. The incidence of thyroid cancer in women has increased by 34 percent in the last decade (compared with 17 percent in men): The age-adjusted incidence rate per 100,000. Coding Hormone Therapy . poorly differentiated thyroid carcinoma (pdtc) is malignant neoplasm of follicular cell origin showing intermediate histopathological patterns between differentiated and undifferentiated thyroid cancers. 1X5A. C56. In a report based on the Surveillance, Epidemiology, and End Results. Survival rates also vary depending on the type of thyroid cancer.